|
平成30年の東京都保菌者検索事業実施結果が確定いたしましたので、下記の通りお知らせします。
食品監視課食中毒調査担当
1 腸管出血性大腸菌の発生状況累計グラフ
（1）散発患者発生動向調査
| |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
| O157VT1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
1 |
0 |
0 |
0 |
0 |
0 |
| O157VT2 |
0 |
0 |
1 |
2 |
0 |
0 |
0 |
0 |
0 |
2 |
0 |
1 |
0 |
3 |
1 |
2 |
2 |
12 |
| O157VT1,2 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
3 |
1 |
1 |
2 |
2 |
3 |
10 |
14 |
4 |
1 |
| その他 |
1 |
0 |
0 |
0 |
1 |
0 |
1 |
2 |
0 |
0 |
0 |
2 |
0 |
1 |
1 |
0 |
4 |
2 |
| 累計 |
1 |
1 |
2 |
4 |
5 |
5 |
6 |
8 |
11 |
14 |
15 |
21 |
24 |
31 |
43 |
59 |
69 |
84 |
| |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
| O157VT1 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
2 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
| O157VT2 |
12 |
0 |
5 |
6 |
8 |
7 |
7 |
1 |
2 |
7 |
6 |
2 |
1 |
0 |
2 |
1 |
0 |
2 |
| O157VT1,2 |
5 |
5 |
4 |
26 |
20 |
18 |
8 |
4 |
6 |
2 |
2 |
3 |
1 |
4 |
0 |
1 |
0 |
0 |
| その他 |
1 |
3 |
5 |
2 |
3 |
6 |
2 |
3 |
1 |
1 |
1 |
4 |
2 |
3 |
0 |
1 |
3 |
0 |
| 累計 |
102 |
110 |
124 |
159 |
190 |
221 |
238 |
248 |
257 |
267 |
276 |
285 |
289 |
297 |
299 |
302 |
305 |
307 |
（２）無症状病原体保有者調査
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| O157VT1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| O157VT2 |
0 |
0 |
1 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
| O157VT1,2 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
| その他 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
1 |
0 |
1 |
2 |
0 |
1 |
0 |
| 累計 |
0 |
0 |
1 |
1 |
2 |
2 |
2 |
2 |
2 |
3 |
4 |
5 |
6 |
8 |
10 |
10 |
11 |
11 |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| O157VT1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| O157VT2 |
1 |
2 |
0 |
4 |
3 |
3 |
1 |
0 |
0 |
2 |
0 |
1 |
0 |
2 |
0 |
0 |
1 |
0 |
| O157VT1,2 |
0 |
0 |
1 |
1 |
1 |
3 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
2 |
0 |
1 |
| その他 |
0 |
0 |
0 |
0 |
0 |
2 |
0 |
1 |
0 |
2 |
2 |
0 |
1 |
2 |
0 |
0 |
0 |
0 |
| 累計 |
12 |
14 |
15 |
20 |
24 |
32 |
33 |
35 |
35 |
39 |
41 |
42 |
43 |
48 |
48 |
50 |
51 |
52 |
2 サルモネラの発生状況累計グラフ
（1）散発患者発生動向調査
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| O4 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
2 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
| O7 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| O9 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| その他 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| 累計 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
2 |
2 |
4 |
4 |
4 |
4 |
5 |
5 |
5 |
5 |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| O4 |
1 |
1 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| O7 |
0 |
0 |
0 |
1 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| O9 |
0 |
0 |
2 |
1 |
1 |
2 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| その他 |
2 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
| 累計 |
8 |
9 |
11 |
14 |
15 |
19 |
19 |
19 |
20 |
21 |
21 |
21 |
21 |
22 |
22 |
22 |
22 |
22 |
（２）無症状病原体保有者調査
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| O4 |
0 |
1 |
0 |
1 |
4 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
1 |
4 |
2 |
1 |
2 |
0 |
| O7 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
2 |
0 |
0 |
0 |
0 |
1 |
| O9 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
2 |
1 |
0 |
| その他 |
0 |
0 |
2 |
2 |
0 |
0 |
1 |
0 |
0 |
2 |
0 |
0 |
1 |
2 |
1 |
1 |
0 |
0 |
| 累計 |
1 |
2 |
4 |
7 |
11 |
11 |
12 |
12 |
12 |
14 |
16 |
16 |
20 |
27 |
30 |
34 |
37 |
38 |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| O4 |
1 |
2 |
4 |
0 |
1 |
0 |
1 |
2 |
0 |
0 |
2 |
0 |
2 |
0 |
0 |
0 |
0 |
0 |
| O7 |
4 |
2 |
2 |
0 |
3 |
1 |
0 |
0 |
1 |
0 |
1 |
0 |
1 |
2 |
1 |
1 |
1 |
0 |
| O9 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| その他 |
1 |
3 |
0 |
1 |
1 |
0 |
2 |
2 |
1 |
5 |
1 |
0 |
0 |
3 |
1 |
1 |
0 |
0 |
| 累計 |
45 |
52 |
58 |
59 |
65 |
66 |
69 |
73 |
75 |
80 |
84 |
84 |
87 |
92 |
94 |
96 |
97 |
97 |
|
